Global
Dr. Suzan Davis

President, CEO & Founder
Dr. Davis is a pharmacist by training and holds a Master's in Regulatory Affairs (MRA) and a Master’s in Business Administration (MBA) from Northeastern University. With more than 24 years of experience in strategic planning, regulatory affairs strategy, regulatory submissions, clinical trial operations and management.
Dr Suzan S. Davis, President and CEO
As founder, President and CEO of Global Regulatory Partners Inc. (GRP), Dr. Suzan Davis provides the overall leadership, business strategy and day to day management at GRP. Her unique and extensive profile includes her experiences with various pharma, biotech and medical device companies. Her impressive international experience encompasses work in the United States, Europe, Latin America and Asia.
She has been directly involved in building Global Regulatory Partner’s team of highly motivated and talented professionals with the appropriate skills, expertise and experience in regulatory affairs, clinical, safety and quality.
Dr. Davis has more than 24 years of experience in strategic planning, regulatory affairs strategy, regulatory submissions, clinical trial operations and management, adverse event reporting and management, quality audits, licensing, CMC, technical transfer and business development within life sciences industry.
Dr. Davis assumed many leadership, senior management and consulting roles in large and small biotech, pharma and medical device companies such as GSK, Pfizer, Genzyme , EMD Sereno, Millennium/Takeda , Forum Pharmaceuticals, Olympus, Smith and Nephew in United States and international markets as well.
During her career, she managed many new products’ development projects and clinical trials in United States and outside United States. In addition to that, she prepared and submitted many IND, NDA, ANDA, BLA, IDE, 510(K), PMA, CE marking to FDA , EMA and other health authorities in Asia and Latin America.
As certified quality auditor by ASQ she conducted many GMP, ISO 13485 and due diligence audits for multiple pharmaceutical and medical device companies in United States, Europe, Asia and Latin America. She also helped many life science companies in the implementation and maintenance of their quality systems in compliance with FDA and ISO 13485 requirements.
Suzan Davis received a PharmD from pharmacy college (Université Paris 1 Panthéon-Sorbonne) in Paris, a Master in Regulatory Affairs (MRA) and a Master in Business Administration (MBA) from Northeastern University in Boston. She is also a certified quality auditor by ASQ , she is certified in US regulatory affairs ( RAC US) and certified in European regulatory affairs (RAC EU) by Regulatory Affairs Professional Society (RAPS).
Global
Jason Faber

Chief Finance Officer
Jason Faber is an experienced senior leader with 20+ years career in commercial lending, credit risk and bank management. Over his career we accumulated a robust knowledge of commercial lending holding positions in various sectors and markets: large corporate specialized lending, middle market, small business and not-for-profit.
CHINA
Michael Zhang

Director of Regulatory Affairs China
Mr. Zhang has over of 10-year experience in the regulatory field with expertise in regulatory strategy and operations for the China market. Mr. Zhang has extensive experience in IND/NDA/MAA/ANDA submissions with NMPA.
KOREA
Jihyoun (Lily) Youm

Director of Regulatory Affairs Korea
Ms. Youm is a certified pharmacist with over 16 years of working experiences in a pharmaceutical industry mainly working in Regulatory Affairs and pharmacovigilance. Ms. Youm has extensive knowledge on regulation for handling from product planning to launch. Having work experiences in various products on such as OTC , pharmaceuticals: New Chemical Entity, Incremental Modified Drug, Generics, Biological products, Orphan products and Narcotics and medical devices.